Cancer chemotherapy originated from observations during World War I that mustard gas exposure caused bone marrow suppression. This led to the direct use of alkylating agents to treat Hodgkin's disease and lymphomas in the 1940s. Key developments included Sidney Farber using antifolates against leukemia in 1948, demonstrating chemotherapy's ability to induce remission. Since then, chemotherapy has expanded to include many classes of drugs such as alkylating agents, antimetabolites, microtubule inhibitors, and targeted therapies. The goal is to achieve log kill of tumor cells through repeated cycles of treatment. Major regimens were developed like CHOP for lymphoma and CMF for breast cancer.